| Serial Number | 79289877 |
| Word Mark | LUNAC |
| Filing Date | Monday, January 27, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, July 6, 2021 |
| Registration Number | 6405774 |
| Registration Date | Tuesday, July 6, 2021 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 20, 2021 |
| Goods and Services | custom manufacture of chemicals, medicines, pharmaceuticals and anticoagulants; custom manufacture of therapeutic products and medical diagnostic products in the nature of pharmaceuticals for the treatment of blood disorders, blood clots and to prevent blood coagulation; consultancy, advisory and information in connection with all of the aforementioned services, namely, providing advisory services regarding the custom manufacture of pharmaceuticals for others |
| Goods and Services | Medical and veterinary preparations, namely pharmaceutical preparations for the treatment of blood disorders, blood clots and to prevent blood coagulation; pharmaceuticals, namely pharmaceutical preparations for the treatment of blood disorders, blood clots and to prevent blood coagulation; medicines, namely pharmaceutical preparations for the treatment of blood disorders; therapeutic medicines and pharmaceuticals, namely pharmaceutical preparations for the treatment of blood disorders; medical diagnostic products, namely diagnostic preparations for medical purposes; anticoagulants; anticoagulants for the treatment of medical conditions; anticoagulants for the treatment of thrombosis and blood clots; anticoagulants for use in the discovery, preclinical and clinical development of therapeutic products and medical diagnostic products; medicines and pharmaceuticals for use in the discovery, preclinical and clinical development of therapeutic products and medical diagnostic products, namely anticoagulants |
| Goods and Services | Scientific and technological services, namely, providing scientific research for medical purposes in the field of blood disorders, blood clots and to prevent blood coagulation; research and design in relation to science, technology, pharmaceuticals, medicine, blood, thrombosis and anticoagulants, namely, providing scientific research for medical purposes in the field of blood disorders, blood clots and to prevent blood coagulation; preparation of scientific reports on anticoagulants for medical and veterinary purposes; engineering of medicines and pharmaceuticals; bimolecular engineering of anticoagulants, namely, the manipulation of oral small molecules for use as anticoagulants; engineering of anticoagulants; engineering of medicines and pharmaceuticals for the treatment of thrombosis and blood clotting; scientific services relating to the discovery, preclinical and clinical development of therapeutic and medical diagnostic products, namely, providing scientific research for medical purposes in the field of blood disorders, blood clots and to prevent blood coagulation; consultancy, advisory and information in connection with all of the aforementioned services, namely, advising regarding scientific research for medical purposes in the field of blood disorders, blood clots and to prevent blood coagulation |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 24, 2020 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 24, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 24, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Lunac Therapeutics Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Lunac Therapeutics Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Lunac Therapeutics Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Friday, July 24, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, July 24, 2020 | ASSIGNED TO EXAMINER |
| Thursday, July 23, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, July 28, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Sunday, September 6, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Sunday, September 27, 2020 | REFUSAL PROCESSED BY IB |
| Monday, July 27, 2020 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 28, 2020 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, September 2, 2020 | REFUSAL PROCESSED BY MPU |
| Wednesday, February 24, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, February 24, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, February 25, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, March 11, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, March 31, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, March 11, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, March 11, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, March 11, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, March 12, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 31, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, March 31, 2021 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Tuesday, July 6, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 17, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, June 17, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, June 17, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, November 29, 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Sunday, April 18, 2021 | NOTIFICATION PROCESSED BY IB |
| Tuesday, April 20, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 20, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, October 6, 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, November 9, 2021 | FINAL DISPOSITION PROCESSED |
| Tuesday, November 9, 2021 | FINAL DISPOSITION NOTICE SENT TO IB |